The Growing Burden of Kidney Disease
Kidney disease statistics for the United States convey the burden of chronic kidney disease (CKD) and end-
Over time, kidney disease statistics show trends and movement. For example, statistics show which ethnic and age groups and geographical regions have the highest incidence of kidney disease. This demographic information helps direct targeted programs to the people who need them most. Statistics can later help measure progress in preventing and treating kidney disease. With the knowledge provided by statistics, researchers and health care providers can make great gains in the fi ght against kidney disease.
Unless otherwise noted, the following statistics are from the United States Renal Data System’s 2010 Annual Data Report and 2011 Annual Data Report.
One in 10 American adults,
more than 20 million, have some level of CKD.
Source: Centers for Disease Control and Prevention
chronic kidney disease (CKD): any condition that causes reduced kidney function over a period of time. CKD is present when a patient’s glomerular filtration rate remains below 60 milliliters per minute for more than 3 months or when a patient’s urine albumin-
acute kidney injury (AKI): sudden, temporary, and sometimes fatal loss of kidney function
incidence: the number of new cases of a disease in a given time period
prevalence: the number of existing cases of a disease at a given point in time
The incidence of CKD is increasing most rapidly in people ages 65 and older.
The incidence of recognized CKD in people ages 65 and older more than doubled between 2000 and 2008.
The incidence of recognized CKD among 20-
The National Institute of Diabetes and Digestive and Kidney Diseases
The prevalence of CKD is growing most rapidly in people ages 60 and older.
Between the 1988–1994 National Health and Nutrition Examination Survey (NHANES) study and the 2003–2006 NHANES study, the prevalence of CKD in people ages 60 and older jumped from 18.8 to 24.5 percent.
During that same period, the prevalence of CKD in people between the ages of 20 and 39 stayed consistently below 0.5 percent.
ESRD Incident Rate
After rising steadily from 1980 to 2001, the incident rate of ESRD
ESRD Incident Rates by Race
ESRD Prevalence and Prevalent Rate
ESRD Treatment Modality
After rising steadily from 1980 to 2006, the annual number of kidney transplants declined in 2007 and 2008.
Mortality Rates for Dialysis Patients
After rising from 1980 to 2001, mortality rates for dialysis patients started to fall every year. By 2008, they had returned to early 1980s levels.
General Graft Survival Rates
The percentage of grafts transplanted in 1980 that survived to 1990 was 25.7. That percentage improved steadily in the following decades, with the survival rate from 1999 to 2009 rising to 44.9.
Graft Survival Rates by Race
While graft survival is lower in African Americans than in Caucasians, patient survival rates are about equal.
Patient Survival Rates for Dialysis and Transplant Patients
At 85.5 percent, the 5-
Treating ESRD patients cost the United States over $40 billion in public and private funds in 2009.
Costs per Patient
vascular access: a general term to describe where blood is removed from and returned to the body during HD. A vascular access may be an arteriovenous (AV) fistula, an AV graft, or a catheter. An AV fistula is the preferred type of vascular access because it causes fewer problems with infection and clotting. Catheters have the most problems with infection.
AV Graft Use among Men and Women
Catheter Use for Vascular Access
Around 18 percent of dialysis patients use a catheter for their vascular access.
Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.
Kidney Disease Statistics for the United States
To place your order NOW! Please CLICK the “PURCHASE BUTTON”
or contact us by E-
Copyright © 2015 KIP Solutions, LLC. All rights reserved.
Information provided on this site is solely for informational purposes only. It is not a substitute for professional medical advice. Do not use this information for diagnosing or treating a health problem or disease, or prescribing of any medications or supplements. Only your healthcare provider should diagnose your healthcare problems and prescribe treatment. None of our statements or information, including health claims, articles, advertising or product information have been evaluated or approved by the United States Food and Drug Administration (FDA). The products or ingredients referred to on this site are not intended to diagnose, treat, cure or prevent any disease. Please consult your healthcare provider before starting any supplement, diet or exercise program, before taking any medications or receiving treatment, particularly if you are currently under medical care. Make sure you carefully read all product labeling and packaging prior to use. If you have or suspect you may have a health problem, do not take any supplements without first consulting and obtaining the approval of your healthcare provider. California Consumers – Proposition 65 requires sellers to notify California consumers of substances that are in many foods, plants, herbs and supplements with the following warning.
WARNING: These products contain chemicals known to the State of California to cause birth defects or other reproductive harm.
* These statements have not been evaluated by
the Food & Drug Administration. This product is
not intended to diagnose, treat, cure or prevent
The content of this site is provided for
informational purposes only and is not medical advice. Always consult your physician
before beginning any diet or exercise program.
On orders over $ 50.00